Luca Bertolaccini Selected Research

Neoplasms (Cancer)

4/2024	Recent advances in lung cancer research: unravelling the future of treatment.
4/2024	In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events.
9/2023	Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (Prospective rAndomized sTudy efficaCy of tHree-dimensional rEconstructions Segmentecomy) study protocol.
4/2023	The Role of Surgery in Primary Chest Wall Tumors: Over 20 Years' Experience in Resection and Reconstruction.
1/2023	Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis.
1/2022	Safety Analysis of Salvage Surgery for Advanced Stages or Metastatic Lung Cancers.
1/2021	Preliminary Results of Extracorporeal Membrane Oxygenation Assisted Tracheal Sleeve Pneumonectomy for Cancer.
1/2020	Treatment of Chylothorax after Lung Resection: Indications, Timing, and Outcomes.
4/2019	A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients.
3/2019	Extra-pleural pneumonectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Bertolaccini Research Topics

Disease

19	Lung Neoplasms (Lung Cancer) 04/2024 - 09/2014
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2017
14	Neoplasms (Cancer) 04/2024 - 08/2013
6	Neoplasm Metastasis (Metastasis) 05/2023 - 12/2014
5	Fistula 03/2024 - 10/2021
5	Hemorrhage 01/2022 - 02/2012
4	Pneumothorax 01/2023 - 12/2009
4	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2014 - 07/2013
3	Malignant Mesothelioma 03/2019 - 10/2015
3	Postoperative Pain 01/2017 - 03/2016
2	Pneumonia (Pneumonitis) 05/2023 - 02/2020
2	Lung Diseases (Lung Disease) 01/2023 - 02/2020
2	Wounds and Injuries (Trauma) 01/2023 - 12/2019
2	Pleural Effusion (Pleural Effusions) 01/2023 - 01/2020
2	Pain (Aches) 12/2022 - 03/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 02/2015
2	Lacerations 12/2019 - 04/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2018 - 08/2016
2	Malignant Pleural Effusion 01/2017 - 01/2016
2	Thymoma (Thymic Carcinoma) 12/2014 - 07/2014
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2023
1	Margins of Excision 09/2023
1	Malnutrition (Nutritional Deficiencies) 05/2023
1	Diabetes Mellitus 05/2023
1	Weight Loss (Weight Reduction) 05/2023
1	Sarcoma (Soft Tissue Sarcoma) 05/2023
1	Rib Fractures (Rib Fracture) 01/2023
1	Infections 01/2023
1	Pleural Empyema (Pyothorax) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Ventricular Fibrillation 01/2022
1	Empyema 01/2022
1	Organizing Pneumonia 02/2020
1	Chylothorax 01/2020
1	Adenocarcinoma of Lung 04/2019
1	Pleural Tuberculosis 03/2019
1	Cardiac Arrhythmias (Arrythmia) 10/2018
1	Solitary Pulmonary Nodule 04/2018
1	Lymphadenopathy 01/2018
1	Lymphadenitis (Adenitis) 01/2018

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2014
2	Air Pollutants (Pollutants, Air)IBA 05/2015 - 03/2010
1	Immune Checkpoint InhibitorsIBA 04/2024
1	CelluloseIBA 02/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2023
1	AnticoagulantsIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2021
1	B7-H1 AntigenIBA 01/2021
1	indolepropanol phosphate (IPP)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 12/2019
1	icotinibIBA 04/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	Cell-Free Nucleic AcidsIBA 04/2019
1	Gefitinib (Iressa)FDA Link 04/2019
1	DNA (Deoxyribonucleic Acid)IBA 04/2019
1	Fluorine-18IBA 04/2018
1	methylamphotericin B (AME)IBA 03/2018
1	SiliconesIBA 01/2018

Therapy/Procedure

11	Pneumonectomy (Lung Volume Reduction) 12/2022 - 09/2014
10	Segmental Mastectomy (Lumpectomy) 04/2024 - 06/2017
8	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 12/2014
7	Length of Stay 12/2023 - 02/2012
6	Immunotherapy 04/2024 - 12/2021
6	Thoracotomy 02/2024 - 03/2016
5	Therapeutics 04/2024 - 10/2015
5	Radiotherapy 03/2022 - 02/2015
4	Operative Surgical Procedures 03/2024 - 01/2018
4	Operative Time 07/2023 - 02/2012
3	Drug Therapy (Chemotherapy) 03/2024 - 01/2022
3	Extracorporeal Membrane Oxygenation 10/2023 - 02/2020
2	Metastasectomy 05/2023 - 07/2022
2	Stents 01/2022 - 02/2012
2	Chest Tubes (Chest Tube) 01/2022 - 01/2020
2	Ligation 01/2020 - 12/2019
2	Pleurodesis 01/2017 - 12/2009
2	Transcutaneous Electric Nerve Stimulation (TENS) 09/2014 - 07/2014
1	Molecular Targeted Therapy 12/2023
1	Combined Modality Therapy 04/2023
1	Palliative Care (Palliative Therapy) 07/2022
1	Left Heart Bypass 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Contraindications 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Patient Readmission 01/2022
1	Punctures 02/2021
1	Induction Chemotherapy 01/2021
1	Surgical Instruments (Clip) 01/2021
1	Lung Transplantation 02/2020
1	Artificial Respiration (Mechanical Ventilation) 02/2020
1	Total Parenteral Nutrition 01/2020
1	Conservative Treatment 01/2020
1	Neoadjuvant Therapy 01/2020
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2020
1	Electrocoagulation (Electrocautery) 12/2019
1	Transplantation 10/2018
1	Mastectomy (Mammectomy) 01/2018